BAJAJ BROKING

Notification
No new Notification messages
Ather Energy IPO is Open!
Apply for the Ather Energy IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

19220

543998

VALIANTLAB

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

VALIANT LABORATORIES LTD performance

Today’s low

Today’s high

₹ 96.00 ₹ 102.43
₹ 96.40

52 week low

52 week high

₹ 75.20 ₹ 168.00
₹ 96.40

Open Price

₹ 98.01

Prev. Close

₹ 99.59

Volume (Shares)

4330.00

Total traded value

₹ 4.17

Upper Circuit

₹ 104.56

Lower Circuit

₹ 94.61

info

VALIANT LABORATORIES LTD Share Price Update

As of the latest trading session, VALIANT LABORATORIES LTD share price is currently at ₹ 96.4, which is down by ₹ -3.18 from its previous closing. Today, the stock has fluctuated between ₹ 96.00 and ₹ 102.43. Over the past year, VALIANT LABORATORIES LTD has achieved a return of -37.36 %. In the last month alone, the return has been 25.49 %. Read More...

VALIANT LABORATORIES LTD fundamentals


  • Market cap (Cr)

    418.85

  • P/E Ratio (TTM)

    -67.65

  • Beta

    1.01

  • Book Value / share

    52.90

  • Return on equity

    -1.70%

  • EPS (TTM)

    0.00

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    1.60

info icon alternate text
  • Market cap (Cr)

    424.46

  • P/E Ratio (TTM)

    -64.27

  • Beta

    1.11

  • Book Value / share

    52.90

  • Return on equity

    -1.70%

  • EPS (TTM)

    0.00

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    1.60

info icon alternate text

VALIANT LABORATORIES LTD Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 35.23
Operating Expense 35.17
Net Profit 1.60
Net Profit Margin (%) 4.54
Earnings Per Share (EPS) 0.37
EBITDA 1.29
Effective Tax Rate (%) -122.22
Particulars SEP 2024 (Values in Cr)
Revenue 21.48
Operating Expense 28.74
Net Profit -5.98
Net Profit Margin (%) -27.83
Earnings Per Share (EPS) -1.39
EBITDA -4.80
Effective Tax Rate (%) -12.40
Particulars JUN 2024 (Values in Cr)
Revenue 18.88
Operating Expense 21.83
Net Profit -1.01
Net Profit Margin (%) -5.34
Earnings Per Share (EPS) -0.23
EBITDA -0.21
Effective Tax Rate (%) -29.87
Particulars MAR 2024 (Values in Cr)
Revenue 30.58
Operating Expense 35.64
Net Profit -1.22
Net Profit Margin (%) -3.98
Earnings Per Share (EPS) -0.32
EBITDA -2.03
Effective Tax Rate (%) 52.15
Particulars DEC 2023 (Values in Cr)
Revenue 40.52
Operating Expense 47.34
Net Profit -3.50
Net Profit Margin (%) -8.63
Earnings Per Share (EPS) -0.81
EBITDA -4.53
Effective Tax Rate (%) 30.55
Particulars MAR 2024 (Values in Cr)
Revenue 182.05
Operating Expense 192.49
Net Profit 0.34
Net Profit Margin (%) 0.18
Earnings Per Share (EPS) 0.08
EBITDA 1.27
Effective Tax Rate (%) 145.33
Particulars MAR 2023 (Values in Cr)
Revenue 333.91
Operating Expense 300.63
Net Profit 29.00
Net Profit Margin (%) 8.68
Earnings Per Share (EPS) 8.91
EBITDA 39.95
Effective Tax Rate (%) 23.96
Particulars MAR 2022 (Values in Cr)
Revenue 291.52
Operating Expense 251.76
Net Profit 27.50
Net Profit Margin (%) 9.43
Earnings Per Share (EPS) 16.99
EBITDA 44.26
Effective Tax Rate (%) 34.07
Particulars MAR 2024 (Values in Cr)
Book Value / Share 54.51
ROE % -1.71
ROCE % -1.63
Total Debt to Total Equity 0.41
EBITDA Margin -1.05
Particulars MAR 2023 (Values in Cr)
Book Value / Share 30.86
ROE % 28.86
ROCE % 23.73
Total Debt to Total Equity 0.60
EBITDA Margin 11.96
Particulars MAR 2024 (Values in Cr)
Book Value / Share 54.52
ROE % -1.70
ROCE % -1.68
Total Debt to Total Equity 0.36
EBITDA Margin -1.05
Particulars MAR 2023 (Values in Cr)
Book Value / Share 30.86
ROE % 33.73
ROCE % 26.00
Total Debt to Total Equity 0.71
EBITDA Margin 11.96
Particulars MAR 2022 (Values in Cr)
Book Value / Share 43.89
ROE % 34.37
ROCE % 37.35
Total Debt to Total Equity 0.39
EBITDA Margin 15.18
Particulars MAR 2021 (Values in Cr)
Book Value / Share 84.36
ROE % 34.53
ROCE % 54.13
Total Debt to Total Equity 0.01
EBITDA Margin 28.19
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 106.21
Total Assets 342.68
Total Liabilities 342.68
Total Equity 236.86
Share Outstanding 43450000
Price to Book Ratio 2.67
Return on Assets (%) 0.09
Return on Capital (%) 0.1
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.34
Total Assets 212.96
Total Liabilities 212.96
Total Equity 100.49
Share Outstanding 32560000
Price to Book Ratio 0.00
Return on Assets (%) 13.61
Return on Capital (%) 18.14
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 96.72
Total Assets 324.72
Total Liabilities 324.72
Total Equity 236.88
Share Outstanding 43450000
Price to Book Ratio 2.67
Return on Assets (%) 0.10
Return on Capital (%) 0.11
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.45
Total Assets 212.75
Total Liabilities 212.75
Total Equity 100.49
Share Outstanding 32560000
Price to Book Ratio 0.00
Return on Assets (%) 13.62
Return on Capital (%) 18.14
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 20.13
Total Assets 181.81
Total Liabilities 181.81
Total Equity 71.46
Share Outstanding 16280000
Price to Book Ratio 0.00
Return on Assets (%) 15.12
Return on Capital (%) 20.81
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 18.93
Total Assets 106.31
Total Liabilities 106.31
Total Equity 88.58
Share Outstanding 10500000
Price to Book Ratio 0.00
Return on Assets (%) 28.77
Return on Capital (%) 34.4
Particulars MAR 2024 (Values in Cr)
Net Income -0.76
Cash from Operations 0.90
Cash from Investing -143.87
Cash from Financing 152.44
Net change in Cash 10.45
Free Cash Flow 46.77
Particulars MAR 2023 (Values in Cr)
Net Income 38.13
Cash from Operations 64.85
Cash from Investing -55.16
Cash from Financing -0.93
Net change in Cash -0.05
Free Cash Flow 102.53
Particulars MAR 2024 (Values in Cr)
Net Income -0.75
Cash from Operations 47.80
Cash from Investing -182.72
Cash from Financing 135.79
Net change in Cash 1.85
Free Cash Flow 51.55
Particulars MAR 2023 (Values in Cr)
Net Income 38.13
Cash from Operations 31.75
Cash from Investing -21.17
Cash from Financing -1.53
Net change in Cash 0.24
Free Cash Flow 38.82
Particulars MAR 2022 (Values in Cr)
Net Income 41.70
Cash from Operations 16.71
Cash from Investing -12.23
Cash from Financing 6.18
Net change in Cash -3.80
Free Cash Flow 23.59
Particulars MAR 2021 (Values in Cr)
Net Income 47.02
Cash from Operations 25.56
Cash from Investing -16.66
Cash from Financing 11.42
Net change in Cash 3.86
Free Cash Flow 27.23
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 37.10 19.95 2.02 284.31 34.11 / 77.70
BLISS GVS PHARMA LTD 122.65 16.07 1.27 1292.37 92.25 / 184.95
CIPLA LTD 1541.00 24.94 4.38 124457.39 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 272.25 22.56 2.76 801.26 145.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 37.10 22.35 6.30 284.31 34.11 / 77.70
AMRUTAJAN HEALTH LTD 679.10 39.81 6.59 1963.32 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8795.90 131.18 32.36 21989.75 5000.00 / 9199.00
BLISS GVS PHARMA LTD 122.65 15.93 1.26 1292.37 92.25 / 184.95

VALIANT LABORATORIES LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
96.40 -3.20 redarrow
red-green-graph indicator
10 Bearish
6 Bullish
  • 5 Days 100.30
  • 26 Days 94.60
  • 10 Days 99.20
  • 50 Days 94.20
  • 12 Days 98.50
  • 100 Days 99.20
  • 20 Days 95.80
  • 200 Days 112.20
100.13 PIVOT

First Support

97.36

First Resistance

102.36

Second Support

95.13

Second Resistance

105.13

Third Support

92.36

Third Resistance

107.36

RSI

56.84

ADX

37.33

MACD

3.83

Williams % R

-41.28

Commodity Channel Index (CCI)

64.30

Date

-

Week

0.0

Same Day

0.0

Month

0.0

1 Year

1.01

3 Year

1.09

Over 1 Month

25.49%

down

Over 1 Year

-37.36%

down

Over 3 Months

0.33%

down

Over 3 Years

0.00%

down

Over 6 Months

-10.70%

down

Over 5 Years

0.00%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

VALIANT LABORATORIES LTD shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
24.41%
Promoter Holdings
74.93%
FII
0.64%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Dhanvallabh Ventures Llp 2.035E7 (46.84%) Shareholding of Promoter and Promoter Group
Paresh Shashikant Shah 4067690.0 (9.36%) Shareholding of Promoter and Promoter Group
Shantilal Shivji Vora 3259190.0 (7.5%) Shareholding of Promoter and Promoter Group
Santosh Shantilal Vora 3259190.0 (7.5%) Shareholding of Promoter and Promoter Group
Kanchan Shantilal Vora 1614690.0 (3.72%) Shareholding of Promoter and Promoter Group
L7 Hitech Private Limited 969958.0 (2.23%) Public Shareholding
Money Logix Securities Private Limited 550000.0 (1.27%) Public Shareholding
Dhirajbhai Vaghjibhai Koradiya 503275.0 (1.16%) Public Shareholding
Rachi Santosh Vora 6930.0 (0.02%) Shareholding of Promoter and Promoter Group
Varsha Paresh Shah 2310.0 (0.01%) Shareholding of Promoter and Promoter Group
Sangita Manoj Jain 1000.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

VALIANT LABORATORIES LTD corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

VALIANT LABORATORIES LTD Share Price

Valiant Laboratories Limited was originally formed as a Partnership Firm under the name and style of M/s. Bharat Chemicals' through Deed of Partnership dated October 17, 1980. The said Partnership Firm, M/s. Bharat Chemicals thereafter converted into a Public Limited Company with the name 'Valiant Laboratories Limited' through certificate of incorporation dated August 16, 2021 issued by the Central Registration Centre, Registrar of Companies.

The Company is an Active Pharmaceutical Ingredient (API) / Bulk Drug manufacturing company having focus on manufacturing of Paracetamol. The Company gradually, commenced manufacturing of Paracetamol by late 1982. Paracetamol (Scientific name: Acetaminophen or para-hydroxyacetanilide - C8H9NO2), is one of the most commonly taken analgesic worldwide and is recommended as the first-line therapy in pain conditions by the World Health Organization (WHO). Paracetamol has several applications such as usage in treatment of headaches, muscle aches, arthritis, back aches, toothaches, cold and fever. It manufacture Paracetamol in various grades such as IP/BP/EP/USP, as per the pharmacopeia requirements of customers.

Paracetamol is available in a variety of forms including syrup form, regular tablets, effervescent tablets, injection, suppository, and other forms. Paracetamol is often found combined with other drugs in many over the counter (OTC) allergy medications, cold medications, sleep medications, pain relievers, and other products.

Presently, the Company is engaged in manufacturing and dealing in Pharmaceuticals and specility chemicals. The manufacturing facility is located at Tarapur Industrial Area, Boisar in the State of Maharashtra, with an annual installed capacity of 9,000 MTPA. Within the Manufacturing Facility located at Tarapur Industrial Area, Palghar, Maharashtra, the Company has an in-house R&D infrastructure which is equipped with analytical laboratory and infrastructure for developmental activities in existing product. The Company is promoted by Shantilal Shivji Vora, Director and Dhanvallabh Ventures LLP (DVL).

In July, 2022 the Company formed its wholly owned subsidiary, Valiant Advanced Sciences Private Limited (VASPL) to diversify the business activities.

The Company has come out with a Public Issue of issuing upto 11,556,000 Equity Shares through fresh issue.

Parent organization Indian Private
NSE symbol VALIANTLAB
Founded 2021
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Valiant Laboratories Ltd?

Answer Field

The share price of Valiant Laboratories Ltd for NSE is ₹ 96.4 and for BSE is ₹ 97.69.

What is the Market Cap of Valiant Laboratories Ltd?

Answer Field

The market cap of Valiant Laboratories Ltd for NSE is ₹ 4,18.85 Cr. and for BSE is ₹ 4,24.46 Cr. as of now.

What is the 52 Week High and Low of Valiant Laboratories Ltd?

Answer Field

The 52 Week High and Low of Valiant Laboratories Ltd for NSE is ₹ 168.00 and ₹ 75.20 and for BSE is ₹ 168.05 and ₹ 75.86.

How to Buy Valiant Laboratories Ltd share?

Answer Field

You can trade in Valiant Laboratories Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Valiant Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been -37.36%.

What is the Current Share Price of Valiant Laboratories Ltd?

Answer Field

Valiant Laboratories Ltd share price is for NSE ₹ 96.4 & for BSE ₹ 97.69 as on Apr 30 2025 03:30 PM.

What is the Market Cap of Valiant Laboratories Ltd Share?

Answer Field

The market cap of Valiant Laboratories Ltd for NSE ₹ 4,18.85 & for BSE ₹ 4,24.46 as on Apr 30 2025 03:30 PM.

What is the P/E Ratio of Valiant Laboratories Ltd Share?

Answer Field

As on Apr 30 2025 03:30 PM the price-to-earnings (PE) ratio for Valiant Laboratories Ltd share is -67.65.

What is the PB ratio of Valiant Laboratories Ltd Share?

Answer Field

As on Apr 30 2025 03:30 PM, the price-to-book (PB) ratio for Valiant Laboratories Ltd share is 52.90.

How to Buy Valiant Laboratories Ltd Share?

Answer Field

You can trade in Valiant Laboratories Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Valiant Laboratories Ltd Share on Bajaj Broking App?

Answer Field

To buy Valiant Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Valiant Laboratories Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|